FTC marks revived ‘prior approval’ merger stance with proposed limits on DaVita


The Federal Trade Commission proposed 10-year acquisition restrictions on dialysis service provider DaVita under the agency’s newly reinstated “prior approval” policy aimed at curbing anticompetitive mergers.

lock iconTHIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.